177 related articles for article (PubMed ID: 24708660)
1. FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized controlled trial.
Reim D; Kim YW; Nam BH; Kim MJ; Yook JH; Park YK; Roh SH; Yu WS; Bae JM
Trials; 2014 Apr; 15():111. PubMed ID: 24708660
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial.
Kim YW; Bae JM; Park YK; Yang HK; Yu W; Yook JH; Noh SH; Han M; Ryu KW; Sohn TS; Lee HJ; Kwon OK; Ryu SY; Lee JH; Kim S; Yoon HM; Eom BW; Choi MG; Kim BS; Jeong O; Suh YS; Yoo MW; Lee IS; Jung MR; An JY; Kim HI; Kim Y; Yang H; Nam BH;
JAMA; 2017 May; 317(20):2097-2104. PubMed ID: 28535237
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding.
Ballester-Clau R; Torres Vicente G; Voltà-Pardo T; López-Barroso L; Cucala-Ramos M; Reñé-Espinet JM; Planella de Rubinat M
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):116-122. PubMed ID: 30335628
[TBL] [Abstract][Full Text] [Related]
4. PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial.
Richards T; Clevenger B; Keidan J; Collier T; Klein AA; Anker SD; Kelly JD
Trials; 2015 Jun; 16():254. PubMed ID: 26041028
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial.
Bielesz B; Lorenz M; Monteforte R; Prikoszovich T; Gabriel M; Wolzt M; Gleiss A; Hörl WH; Sunder-Plassmann G
Clin J Am Soc Nephrol; 2021 Oct; 16(10):1512-1521. PubMed ID: 34470831
[TBL] [Abstract][Full Text] [Related]
6. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea.
Jang JH; Kim Y; Park S; Kim K; Kim SJ; Kim WS; Jung CW; Lee J; Lee SH
PLoS Med; 2020 Jun; 17(6):e1003091. PubMed ID: 32511251
[TBL] [Abstract][Full Text] [Related]
8. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
Van Wyck DB; Martens MG; Seid MH; Baker JB; Mangione A
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.
Richard N; Arab-Hocine N; Vannier M; Leblanc-Boubchir R; Pelaquier A; Boruchowicz A; Musikas M; Amil M; Fumery M; Nahon S; Arotcarena R; Gelsi E; Maurin A; Hébuterne X; Savoye G
Age Ageing; 2024 May; 53(5):. PubMed ID: 38706390
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Intravenous Iron in Anemic Patients Undergoing Major Abdominal Surgery May Not PREVENTT Blood Transfusions But Still Contribute to the Objectives of Patient Blood Management.
Hardy JF; Farmer SL; Auerbach M; Frank SM; Javidroozi M; Leahy MF; Meier J; Ozawa S; Shander A
Anesth Analg; 2021 Apr; 132(4):1174-1177. PubMed ID: 33723195
[No Abstract] [Full Text] [Related]
11. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
Wolf M; Rubin J; Achebe M; Econs MJ; Peacock M; Imel EA; Thomsen LL; Carpenter TO; Weber T; Brandenburg V; Zoller H
JAMA; 2020 Feb; 323(5):432-443. PubMed ID: 32016310
[TBL] [Abstract][Full Text] [Related]
12. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
Urato AC
Obstet Gynecol; 2008 Sep; 112(3):703. PubMed ID: 18757678
[No Abstract] [Full Text] [Related]
13. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.
Miñana G; Cardells I; Palau P; Llàcer P; Fácila L; Almenar L; López-Lereu MP; Monmeneu JV; Amiguet M; González J; Serrano A; Montagud V; López-Vilella R; Valero E; García-Blas S; Bodí V; de la Espriella-Juan R; Sanchis J; Chorro FJ; Bayés-Genís A; Núñez J;
Clin Cardiol; 2018 Jun; 41(6):729-735. PubMed ID: 29607528
[TBL] [Abstract][Full Text] [Related]
14. Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
Filippatos G; Ponikowski P; Farmakis D; Anker SD; Butler J; Fabien V; Kirwan BA; Macdougall IC; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA;
Circulation; 2023 May; 147(22):1640-1653. PubMed ID: 37051919
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
Mahey R; Kriplani A; Mogili KD; Bhatla N; Kachhawa G; Saxena R
Int J Gynaecol Obstet; 2016 Apr; 133(1):43-8. PubMed ID: 26868063
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana - An interventional study.
Kant S; Kaur R; Ahamed F; Singh A; Malhotra S; Kumar R
Indian J Public Health; 2020; 64(2):168-172. PubMed ID: 32584300
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Onken JE; Bregman DB; Harrington RA; Morris D; Acs P; Akright B; Barish C; Bhaskar BS; Smith-Nguyen GN; Butcher A; Koch TA; Goodnough LT
Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
[TBL] [Abstract][Full Text] [Related]
18. The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial.
Rowlands M; Forward DP; Sahota O; Moppett IK
Trials; 2013 Sep; 14():288. PubMed ID: 24015990
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer
Mulder MB; van den Hoek HL; Birnie E; van Tilburg AJP; Westerman EM
Br J Clin Pharmacol; 2019 Feb; 85(2):385-392. PubMed ID: 30393904
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
Howaldt S; Domènech E; Martinez N; Schmidt C; Bokemeyer B
Inflamm Bowel Dis; 2022 Mar; 28(3):373-384. PubMed ID: 33988236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
